首页> 美国卫生研究院文献>NPJ Vaccines >Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
【2h】

Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis

机译:一种呼吸性呼吸乳头状瘤病的新型治疗疫苗的临床前研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

a Experimental design of in vitro stimulation of T cells isolated from the blood of patients with HPV6 or HPV11-driven RRP or healthy donors with PRGN-2012. Concentrations of b IFNγ, c granzyme B, and d GM-CSF in the supernatant of cocultures assessing HPV antigen-specific responses in T lymphocytes isolated from the blood of patients with HPV11-driven RRP (n = 3, black bars), HPV6-driven RRP (n = 2, gray bars), or healthy donors (n = 3, open bars) following two rounds of in vitro simulation with PRGN-2012 or empty GC46. Displayed results are the result of HPV antigen-specific stimulation after baseline cytokine concentrations following in vitro stimulation with empty GC46 were subtracted. Similar results were observed in two independent assays. PBMC peripheral blood mononuclear cells, DC dendritic cells, HD healthy donor, empty GC46 GC46 gorilla adenovirus without HPV gene inserts (control virus). **p < 0.01; ***p < 0.001; Student’s t test.
机译:HPV6或HPV11驱动的RRP患者血液中分离的T细胞体外刺激的实验设计与PRGN-2012。 BIFNγ,C granzzyme B和D GM-CSF的浓度在患有HPV11驱动的RRP患者血液中分离的T淋巴细胞中的HPV抗原特异性反应(n = 3,黑条),HPV6-通过PRGN-2012或空GC46,在两轮体外模拟之后驱动RRP(n = 2,灰色条)或健康供体(n = 3,开口条)。显示结果是在对空心GC46进行体外刺激后基线细胞因子浓度后的HPV抗原特异性刺激的结果。在两个独立的测定中观察到类似的结果。 PBMC外周血单核细胞,DC树突细胞,高清健康供体,空GC46 GC46 Gorilla腺病毒没有HPV基因插入(对照病毒)。 ** p <0.01; *** p <0.001;学生的T测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号